首页>Blood cells, molecules and diseases>Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem
Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem
作者单位：Department of Diagnostic Radiology, Shaare Zedek Medical Center, The Hebrew University and Hadassah[1]Gaucher Clinic, Shaare Zedek Medical Center, The Hebrew University and Hadassah Medical School[2]Genetics Unit, Shaare Zedek Medical Center, The Hebrew University and Hadassah Medical School[3]
换一批
